MedTrace Logo

EDA-Based Adaptive Support in VR ALS Training

NCT07650019 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2026-07-02

No results posted yet for this study

Summary

This randomized controlled study aims to investigate the effects of an electrodermal activity (EDA)-based adaptive support system on performance during virtual reality (VR)-based advanced life support (ALS) training. Participants' stress levels will be continuously monitored through EDA during the simulation. When stress exceeds a predefined threshold, the adaptive system will automatically activate a support mode that provides additional guidance and time. The performance outcomes of participants receiving adaptive support will be compared with those receiving standard VR training. The study will also examine the role of presence, anxiety, social anxiety, and personality traits in the relationship between stress and performance.

Conditions

  • Adaptive Support Condition
  • Standard Training Condition

Interventions

OTHER

EDA-Based Adaptive Support System

Participants receive VR-based advanced life support training with an electrodermal activity (EDA)-based adaptive support system that automatically provides additional guidance, more frequent instructions, and extended response time when stress levels exceed a predefined threshold.

OTHER

Standard VR-Based Training

Participants receive standard VR-based advanced life support training without adaptive support. Although electrodermal activity (EDA) is monitored during the simulation, the training flow remains unchanged regardless of stress levels.

Sponsors & Collaborators

  • Acibadem University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2026-07-31
Completion
2026-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07650019 on ClinicalTrials.gov